Literature DB >> 11959104

Involvement of tumor necrosis factor alpha, rather than interleukin-1alpha/beta or nitric oxides in the heme oxygenase-1 gene expression by lipopolysaccharide in the mouse liver.

Takiko Oguro1, Yuko Takahashi, Takashi Ashino, Atsushi Takaki, Seiji Shioda, Reiko Horai, Masahide Asano, Kenji Sekikawa, Yoichiro Iwakura, Takemi Yoshida.   

Abstract

Heme oxygenase-1 (HO-1) is induced under various oxidative stress conditions, such as lipopolysaccharide (LPS) insult. Induction of HO-1 by LPS is reported to be mediated through interleukin-1beta (IL-1beta), rather than other inflammatory cytokines in the mouse liver. However, we found that IL-1alpha/beta knockout (KO) mice responded well to LPS insult, as did wild-type mice with respect to HO-1 mRNA induction (about 30-fold increase). In contrast, tumor necrosis factor alpha KO (TNFalphaKO) mice responded very weakly to LPS in the HO-1 mRNA expression, but not metallothionein mRNA. Recent studies reveal that nitric oxide from Kupffer cells is involved in HO-1 induction in the liver produced by LPS. Therefore, nitrite and nitrate concentrations in the liver were also measured and these parameters did not increase in either IL-1KO or TNFalphaKO. In addition, the phosphorylation of c-JUN N-terminal kinase (JNK) and p38, but not extracellular signal-regulated kinase, was very low in TNFalphaKO mice due to LPS administration. All of these findings indicate that TNFalpha is a major candidate to trigger HO-1 induction in response to LPS stimulation, and that its message is likely transduced through JNK and p38 pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11959104     DOI: 10.1016/s0014-5793(02)02502-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Impact of aging on pulmonary responses to acute ozone exposure in mice: role of TNFR1.

Authors:  Stephanie A Shore; Erin S Williams; Lucas Chen; Leandro A P Benedito; David I Kasahara; Ming Zhu
Journal:  Inhal Toxicol       Date:  2011-11-08       Impact factor: 2.724

2.  p38 mitogen-activated protein kinase-dependent chemokine production, leukocyte recruitment, and hepatocellular apoptosis in endotoxemic liver injury.

Authors:  Daniel Klintman; Xiang Li; Stefan Santen; Rene Schramm; Bengt Jeppsson; Henrik Thorlacius
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

3.  Treatment with histone deacetylase inhibitor attenuates MAP kinase mediated liver injury in a lethal model of septic shock.

Authors:  Robert A Finkelstein; Yongqing Li; Baoling Liu; Fahad Shuja; Eugene Fukudome; George C Velmahos; Marc deMoya; Hasan B Alam
Journal:  J Surg Res       Date:  2010-05-10       Impact factor: 2.192

4.  Elevated activation of ERK1 and ERK2 accompany enhanced liver injury following alcohol binge in chronically ethanol-fed rats.

Authors:  Annayya R Aroor; Daniel E Jackson; Shivendra D Shukla
Journal:  Alcohol Clin Exp Res       Date:  2011-07-25       Impact factor: 3.455

5.  Melatonin treatment in old mice enables a more youthful response to LPS in the brain.

Authors:  V M Perreau; S C Bondy; C W Cotman; K G Sharman; E H Sharman
Journal:  J Neuroimmunol       Date:  2006-10-30       Impact factor: 3.478

6.  Reduced antioxidant level and increased oxidative damage in intact liver lobes during ischaemia-reperfusion.

Authors:  László Váli; Gabriella Taba; Klára Szentmihályi; Hedvig Fébel; Tímea Kurucz; Zsolt Pallai; Péter Kupcsulik; Anna Blázovics
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

7.  The role of endosomal escape and mitogen-activated protein kinases in adenoviral activation of the innate immune response.

Authors:  Jeffrey S Smith; Zhili Xu; Jie Tian; Donna J Palmer; Philip Ng; Andrew P Byrnes
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

8.  Roles of bone-marrow-derived cells and inflammatory cytokines in neointimal hyperplasia after vascular injury.

Authors:  Makoto Shoji; Shinji Koba; Youichi Kobayashi
Journal:  Biomed Res Int       Date:  2014-01-14       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.